“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
Reviews
There are no reviews yet.
Be the first to review “Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients” Cancel reply
Reviews
There are no reviews yet.